A Selenium Containing Inhibitor for the Treatment of Hepatocellular Cancer

Hepatocellular carcinoma (HCC) is the third most deadly cancer in the world. New treatment strategies are desperately needed due to limited standard therapies. Activation of the Erk, Akt, and STAT3pathways is implicated in the prognosis of HCC. The Se,Se′-1,4-phenylenebis(1,2-ethanediyl) bisisoselen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmaceuticals (Basel)
Main Authors: Tagaram, Hephzibah Rani S., Desai, Dhimant, Li, Guangfu, Liu, Dai, Rountree, C. Bart, Gowda, Kavitha, Berg, Arthur, Amin, Shantu, Staveley-O’Carroll, Kevin F., Kimchi, Eric T.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4932536/
https://ncbi.nlm.nih.gov/pubmed/27023566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph9020018
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados